Fertility after breast cancer treatment

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 173, Issue 1, 2014, Pages 13-18

  Kasum, Miro ^a   Beketić Orešković, Lidija ^b   Peddi, Parvin F ^c   Orešković, Slavko ^a   Johnson, Rebecca H ^d  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Breast cancer; Fertility; Pregnancy; Treatment

Indexed keywords

ANTHRACYCLINE; ANTIESTROGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN AGONIST; LETROZOLE; METHOTREXATE; TAMOXIFEN; TRASTUZUMAB;

ABLATION THERAPY; ABORTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONGENITAL MALFORMATION; CRYOPRESERVATION; EARLY MENOPAUSE; EMBRYO TRANSFER; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FREEZING; HUMAN; IN VITRO OOCYTE MATURATION; INFERTILITY; LOW BIRTH WEIGHT; OOCYTE; OOCYTE RETRIEVAL; PREGNANCY; PREMATURE LABOR; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; SPERM DONOR; SURGICAL TECHNIQUE; TERATOGENESIS; TISSUE PRESERVATION; TOXICITY; VITRIFICATION;

BREAST CANCER; FERTILITY; PREGNANCY; TREATMENT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FERTILITY; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; PREGNANCY;

EID: 84893695915     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.11.009     Document Type: Article

References (60)

1. D.F. Merlo, M. Ceppi, and R. Filiberti et al. Breast cancer incidence trends in European women aged 20-39 years at diagnosis Breast Cancer Res Treat 134 2012 363 370
2. R.H. Johnson, F.L. Chien, and A. Bleyer Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009 J Am Med Assoc 27 2013 309 312
3. S.H. Lee, K. Akuete, J. Fulton, D. Chelmow, M.A. Chung, and B. Cady An increased risk of breast disease after delayed parity Am J Surg 185 2003 409 412
4. S. Lee, E. Heytens, F. Moy, S. Ozkavukcu, and K. Oktay Determinants of access to fertility preservation in women with breast cancer Fertil Steril 95 2011 1932 1936
5. R. Arriagada, M.G. Le, G. Contesso, J.M. Guinebretiere, F. Rochard, and M. Spielmann Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer Ann Oncol 13 2002 1404 1413
6. N.A. Malamos, G.P. Stathopoulos, A. Keramopoulos, J. Papadiamantis, and S. Vassilaros Pregnancy and offspring after the appearance of breast cancer Oncology 53 1996 471 475
7. S.N. Kalantaridou, S.R. Davis, and L.M. Nelson Premature ovarian failure Endocrinol Metab Clin North Am 27 1998 989 1006
8. L.A. Emens, and N.E. Davidson Adjuvant hormonal therapy for premenopausal women with breast cancer Clin Cancer Res 9 2003 486s 494s
9. O. Oktem, and K. Oktay Fertility preservation for breast cancer patients Semin Reprod Med 27 2009 486 492
10. A.C. Voogd, M. Nielsen, and J.L. Peterse Difference on risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
11. A. Goldhirsch, J.H. Glick, R.D. Gelber, A.S. Coates, and H.J. Senn Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer J Clin Oncol 19 2001 3817 3827
12. K.H. Dow, J.T. Harris, and C. Roy Pregnancy after breast conserving surgery and radiation therapy for breast cancer Inst Monog 16 1994 131 137
13. S. Higgins, and B.G. Hafty Pregnancy and lactation after breast conserving therapy for early stage breast cancer Cancer 73 1994 2175 2180
14. S.E. Minton, and P.N. Munster Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer Cancer Control 9 2002 466 472
15. A.M. Chiarelli, L.D. Marett, and G. Darlington Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario Can Am J Epidemiol 150 1999 245 254
16. A. Surbone, and J.A. Petrek Childbearing issues in breast carcinoma survivors Cancer 19 1997 1271 1278
17. Z. Blumenfeld Ovarian rescue/protection from chemotherapeutic agents J Soc Gynecol Investig 8 2001 560 564
18. R. Sutton, A.U. Buzdar, and G.N. Hortobagyi Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients Cancer 65 1990 847 850
19. D.C. Doll, O.S. Ringenberg, and J.W. Yarbro Antineoplastic agents and pregnancy Semin Oncol 16 1989 337 346
20. K.M.E. Hahn, P.H. Johnson, and N. Gordon et al. Treatment in pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero Cancer 107 2006 1219 1226
21. N. Germann, F. Geoffinet, and F. Goldwasser Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients Ann Oncol 15 2004 146 150
22. A.A. Bader, D. Schlembach, and K.F. Tamussino et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy Lancet Oncol 8 2007 79 81
23. J.J. Mulvihill, E.A. McKeen, F. Rosner, and M.H. Zarrabi Pregnancy outcome in cancer patients Cancer 60 1987 1143 1150
24. L.J. Blakely, A.U. Buzdar, and J.A. Lozada et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence Cancer 100 2004 465 469
25. J. Valle, J. Clemons, S. Haycs, L. Fallowfield, and A. Howel Contraceptive use by women receiving chemotherapy for breast cancer Breast 7 1998 143 149
26. M. Baum Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen Breast Cancer Res Treat 57 1999 30 35
27. M. Castiglione-Gertsch, M.A. O'Neill, and R.D. Gelber et al. Is the addition of adjuvant chemotherapy always necessary in node negative (N-) pre/perimenopausal breast cancer patients who receive goserelin Proc Am Soc Clin Oncol 21 2002 38a 41a
28. M. Berliere, C. Galant, and G. Marques et al. LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen Eur J Cancer 40 2004 1855 1861
29. E.A. Elgidy, D.O. El-Haieg, and O.M. Khorshid et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial Obstet Gynecol 121 2013 78 86
30. A. Goldhirsch, R.D. Gelber, and M. Castiglione The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group Ann Oncol 1 1990 183 188
31. O. Pagani, A. O'Neill, and M. Castiglione et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI Eur J Cancer 34 1998 632 640
32. International Breast Cancer Study Group (IBCSG), M. Castiglione-Gertsch, and A. O'Neill et al. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial J Natl Cancer Inst 95 2003 1833 1846
33. A.R. Bianco, L. Del Mastro, and C. Gallo et al. Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer Br J Cancer 63 1991 799 803
34. W. Jonat, M. Kaufmann, and W. Sauerbrei et al. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study J Clin Oncol 20 2002 4628 4635
35. Y.L. Tham, K. Sexton, H. Weiss, R. Elledge, L.C. Friedman, and R. Kramer The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane Am J Clin Oncol 30 2007 126 132
36. H. Roché, P. Kerbrat, and J. Bonneterre et al. Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial Ann Oncol 17 2006 1221 1227
37. E. Luporsi, and B. Weber The effects of breast cancer chemotherapy on menstrual function Proc Am Soc Clin Oncol 17 1998 155A [abstr 595]
38. F. Borde, I. Chapelle-Marcillac, and P. Fumoleau Role of chemo-induced amenorrhea in premenopausal, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group data base Breast Cancer Res Treat 82 2003 S30 [abstr 138]
39. P.A. Ganz, S.R. Land, and C.E. Geyer Jr. et al. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial J Clin Oncol 29 2011 1110 1116
40. M. Fornier, S. Modi, K. Panageas, L. Norton, and C. Hudis Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane Cancer 104 2005 1575 1579
41. S. Samuelkutty, O. Gluz, and S. Mohrmann Chemotherapy-induced amenorrhea (CIA) in patients treated with adjuvant CEF/CMF or EC/docetaxel: analysis from a phase III randomized EC/Doc trial Breast Cancer Res Treat 94 2005 S105 [abstr 2063]
42. M. Martin, T. Pienkowski, and J. Mackey et al. Adjuvant docetaxel for node-positive breast cancer N Engl J Med 352 2005 2302 2313
43. E. El Hussein, and S.L. Tan Successful in vitro fertilization and embryo transfer after treatment of invasive carcinoma of the breast Fertil Steril 58 1992 194 196
44. S.J. Prest, E.E. May, and B.R. Westley The estrogen-regulated protein TFF1, stimulates migration of human breast cancer cells FASSEB J 16 2002 592 594
45. M.J. Mourits, E.G. De Vries, P.H. Willemse, K.A. Ten Hoor, H. Hollema, and A.G. Va der Zee Tamoxifen treatment and gynecologic side effects: a review Obstet Gynecol 97 2000 855 856
46. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum Reprod 18 2003 90 95
47. K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation J Clin Oncol 23 2005 4347 4353
48. J. Reddy, and K. Oktay Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer Fertil Steril 98 2012 1363 1369
49. C. Decanter, and J. Gligorov Oocyte/embryo cryopreservation before chemotherapy for breast cancer Gynecol Obstet Fertil 39 2011 501 503
50. J. Donnez, M.M. Dolmans, and D. Demylle et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue Lancet 364 2004 1405 1410
51. J. Donnez, M.M. Dolmans, and A. Pellicer et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation Fertil Steril 99 2013 1503 1513
52. K. Oktay, and O. Oktem Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience Fertil Steril 93 2010 762 768
53. J.A. Garcia-Velasco, J. Domingo, A. Cobo, M. Martínez, L. Carmona, and A. Pellicer Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications Fertil Steril 99 2013 1994 1999
54. J. Barcroft, N. Dayoub, and K.J. Thong Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation J Assist Reprod Gen 30 2013 1407 1413
55. K. Oktay, E. Buyuk, K.A. Rodriguez-Wallberg, and G. Sahin In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation Reprod Biomed Online 20 2010 634 638
56. E. Shalom-Paz, B. Almog, and F. Shehata et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification Reprod Med Online 21 2010 566 571
57. R.C. Chian, P.S. Uzelac, and G. Nargund In vitro maturation of human immature oocytes for fertility preservation Fertil Steril 99 2013 1173 1181
58. M.M. Dolmans, V. Luyckx, and J. Donnez Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue Fertil Steril 99 2013 1514 1522
59. K.A. Rodriguez-Wallberg, and K. Oktay Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer Oncologist 17 2012 1409 1417
60. S. Titus, F. Li, and R. Stobezki et al. Impairment of BRCA 1-related DNA double strand break repair leads to ovarian aging in mice and humans Sci Transl Med 5 2013 172ra21